Your browser doesn't support javascript.
loading
Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning.
Antonucci, Linda A; Pergola, Giulio; Rampino, Antonio; Rocca, Paola; Rossi, Alessandro; Amore, Mario; Aguglia, Eugenio; Bellomo, Antonello; Bianchini, Valeria; Brasso, Claudio; Bucci, Paola; Carpiniello, Bernardo; Dell'Osso, Liliana; di Fabio, Fabio; di Giannantonio, Massimo; Fagiolini, Andrea; Giordano, Giulia Maria; Marcatilli, Matteo; Marchesi, Carlo; Meneguzzo, Paolo; Monteleone, Palmiero; Pompili, Maurizio; Rossi, Rodolfo; Siracusano, Alberto; Vita, Antonio; Zeppegno, Patrizia; Galderisi, Silvana; Bertolino, Alessandro; Maj, Mario.
Afiliação
  • Antonucci LA; Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Pergola G; Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Rampino A; Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Rocca P; Department of Neuroscience, Section of Psychiatry, University of Turin, Turin, Italy.
  • Rossi A; Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Amore M; Section of Psychiatry, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy.
  • Aguglia E; Department of Clinical and Molecular Biomedicine, Psychiatry Unit, University of Catania, Catania, Italy.
  • Bellomo A; Psychiatry Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy.
  • Bianchini V; Unit of Psychiatry, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
  • Brasso C; Department of Neuroscience, Section of Psychiatry, University of Turin, Turin, Italy.
  • Bucci P; Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Carpiniello B; Section of Psychiatry, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy.
  • Dell'Osso L; Section of Psychiatry, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • di Fabio F; Department of Neurology and Psychiatry, "La Sapienza" University of Rome, Rome, Italy.
  • di Giannantonio M; Department of Neuroscience and Imaging, "G. D'Annunzio" University, Chieti, Italy.
  • Fagiolini A; Department of Molecular Medicine and Clinical Department of Mental Health, University of Siena, Siena, Italy.
  • Giordano GM; Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Marcatilli M; Department of Psychiatry, University of Milan, Milan, Italy.
  • Marchesi C; Department of Neuroscience, Psychiatry Unit, University of Parma, Parma, Italy.
  • Meneguzzo P; Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy.
  • Monteleone P; Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana" Section of Neuroscience, University of Salerno, Salerno, Italy.
  • Pompili M; Department of Neurosciences, Mental Health and Sensory Organs, S. Andrea Hospital, "La Sapienza" University of Rome, Rome, Italy.
  • Rossi R; Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Siracusano A; Department of Systems Medicine, Psychiatry and Clinical Psychology Unit, "Tor Vergata" University of Rome, Rome, Italy.
  • Vita A; Psychiatric Unit, School of Medicine, University of Brescia, Brescia, Italy.
  • Zeppegno P; Department of Mental Health, Spedali Civili Hospital, Brescia, Italy.
  • Galderisi S; Department of Translational Medicine, Psychiatric Unit, University of Eastern Piedmont, Novara, Italy.
  • Bertolino A; Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Maj M; Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
Psychol Med ; 53(12): 5717-5728, 2023 09.
Article em En | MEDLINE | ID: mdl-36217912
BACKGROUND: Resilience is defined as the ability to modify thoughts to cope with stressful events. Patients with schizophrenia (SCZ) having higher resilience (HR) levels show less severe symptoms and better real-life functioning. However, the clinical factors contributing to determine resilience levels in patients remain unclear. Thus, based on psychological, historical, clinical and environmental variables, we built a supervised machine learning algorithm to classify patients with HR or lower resilience (LR). METHODS: SCZ from the Italian Network for Research on Psychoses (N = 598 in the Discovery sample, N = 298 in the Validation sample) underwent historical, clinical, psychological, environmental and resilience assessments. A Support Vector Machine algorithm (based on 85 variables extracted from the above-mentioned assessments) was built in the Discovery sample, and replicated in the Validation sample, to classify between HR and LR patients, within a nested, Leave-Site-Out Cross-Validation framework. We then investigated whether algorithm decision scores were associated with the cognitive and clinical characteristics of patients. RESULTS: The algorithm classified patients as HR or LR with a Balanced Accuracy of 74.5% (p < 0.0001) in the Discovery sample, and 80.2% in the Validation sample. Higher self-esteem, larger social network and use of adaptive coping strategies were the variables most frequently chosen by the algorithm to generate decisions. Correlations between algorithm decision scores, socio-cognitive abilities, and symptom severity were significant (pFDR < 0.05). CONCLUSIONS: We identified an accurate, meaningful and generalizable clinical-psychological signature associated with resilience in SCZ. This study delivers relevant information regarding psychological and clinical factors that non-pharmacological interventions could target in schizophrenia.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Resiliência Psicológica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Resiliência Psicológica Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Psychol Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália